Medscape

Oxygen for Moderate COPD?

Nevertheless, further studies were validated not only because there were indications that a subset of patients with moderately severe COPD might have benefitted by oxygen supplementation but also ...
Healio

Ensifentrine improves outcomes in both moderate, severe COPD

Please provide your email address to receive an email when new articles are posted on . Patients with moderate or severe COPD experienced improvements with 3 mg of twice-daily ensifentrine. Study ...
Healio

24-week ensifentrine improves dyspnea in moderate to severe COPD

Please provide your email address to receive an email when new articles are posted on . Across several subgroups, more patients receiving ensifentrine vs. placebo were classified as Transitional ...
Business Wire

PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial

WILMINGTON, Del.--(BUSINESS WIRE)--Full results from the positive Phase III ETHOS trial showed AstraZeneca’s triple-combination therapy PT010 (budesonide ...
MedPage Today

USPSTF COPD Recommendations: A Fresh Look

"The evidence we have in persons with mild-to-moderate COPD, or who are minimally symptomatic, on reducing exacerbations and improving quality of life is still very limited." — Jennifer S. Lin, MD, ...
WebMD

Treatments for Moderate to Severe COPD

There’s no cure for chronic obstructive pulmonary disease (COPD). But there are things you can do to stay active, breathe easier, and live longer -- even if your condition is more advanced. Ask your ...
MedPage Today

Home Oxygen Therapy May Not Benefit Patients With COPD and Moderate Hypoxemia

The clinical and survival benefit of home oxygen therapy, both LTOT and nocturnal oxygen therapy, for patients with COPD and moderate hypoxemia was evaluated in this meta-analysis. Home oxygen therapy ...
European Medical Journal

COPD Exacerbation Risk Spikes After Stopping LAMA or ICS

FLAME analysis suggests COPD exacerbation risk spikes for 3 months after stopping LAMA or ICS, underscoring adherence and careful step-down.
The American Journal of Managed Care

COPD Exacerbation Costs in the IMPACT Study: A Within-Trial Analysis

Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic ...
News Medical

Diabetes medications may help lower COPD flare-up risk, study finds

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary ...
EurekAlert!

Emphysema at CT lung screening increases death risk in asymptomatic adults

OAK BROOK, Ill. – Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic ...